Chronica is a San Diego digital-health company that runs remote patient monitoring (RPM) and chronic care management (CCM) as a managed service. Built on parent company Hifinite Health's hiCare platform, Chronica pairs a cloud-based, HIPAA-compliant software stack with the parts most clinics don't want to build themselves: the connected devices, the in-house clinicians, the call center, and the billing paperwork tied to CMS reimbursement codes. Providers - from outpatient practices to hospitals, ACOs, and home-health agencies - get to extend care beyond the exam room without upfront costs, long contracts, or patient minimums.
Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.